Literature DB >> 2413287

A possible central action of prazosin and ketanserin to cause hypotension.

I W Copeland, G A Bentley.   

Abstract

Cats anesthetized with chloralose were used to study the cardiovascular effects of prazosin and ketanserin infused into the vertebral artery. It was found that both drugs, when given by this route, caused hypotension at doses which were ineffective if given intravenously. Hypotensive doses of prazosin or ketanserin infused into the vertebral artery had no effect at all on the pressor response to intravenous noradrenaline. Prazosin caused a small tachycardia while ketanserin decreased heart rate. At the doses used, neither of these drugs infused into the vertebral artery caused any significant change in the cardiovascular response to bilateral carotid occlusion, 30 degrees head-up tilt, or electrical stimulation of the central end of the cut brachial nerve. It is concluded that these effects of prazosin and ketanserin, administered into the vertebral artery, do not involve direct action on vascular tissue but are probably of central origin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413287     DOI: 10.1097/00005344-198509000-00002

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  5 in total

Review 1.  The role of 5-hydroxytryptamine and 5-hydroxytryptaminergic mechanisms in hypertension.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

2.  Antihypertensive treatment with ketanserin shows no evidence of vascular serotonin2-receptor and alpha 1-adrenoceptor blockade.

Authors:  G J Blauw; C J Doorenbos; T A Bruning; P van Brummelen; P A van Zwieten
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 3.  Pharmacology of antihypertensive agents with multiple actions.

Authors:  P A van Zwieten
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 4.  Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity.

Authors:  P A van Zwieten; G J Blauw; P van Brummelen
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 5.  Different types of centrally acting antihypertensives and their targets in the central nervous system.

Authors:  P A van Zwieten; J P Chalmers
Journal:  Cardiovasc Drugs Ther       Date:  1994-12       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.